-
1 . Academic Journal
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
- 저자
- by Norton, Sam; Lempp, Heidi; Opena, Maria; Subesinghe, Sujith; Garrood, Toby, et al.
- 소스
- In The Lancet 2-8 March 2024 403(10429):838-849
-
-
-
-
-
7 . Periodical
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
- 저자
- by Cope, Andrew P; Jasenecova, Marianna; Vasconcelos, Joana C; Filer, Andrew; Raza, Karim, et al.
- 소스
- The Lancet; March 2024, Vol. 403 Issue: 10429 p838-849, 12p
-
7 . Periodical
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
- 저자
- by Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia, et al.
- 소스
- The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p
-
7 . Periodical
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- 저자
- by Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia, et al.
- 소스
- The Lancet; May 2021, Vol. 397 Issue: 10285 p1637-1645, 9p
-
7 . Periodical
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- 저자
- by Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia, et al.
- 소스
- The Lancet; 20210101, Issue: Preprints